MedTrace Logo

Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years

NCT01838096 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2022-02-02

No results posted yet for this study

Summary

This study will evaluate clinical outcome on patients who undergo cementless 4th generation ceramic (BIOLOX®delta, CeramTec GmbH, Plochingen, Germany) on ceramic (CoC) bearing total hip aArthroplasty ("THA") in patients younger than 30 years.

Conditions

  • Advanced Hip Disease

Interventions

DEVICE

THA using 4th generation CoC

Sponsors & Collaborators

  • CeramTec GmbH

    collaborator UNKNOWN

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Kyung-Hoi Koo, Professor · Seoul National University Bundang Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2023-11-30
Completion
2023-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01838096 on ClinicalTrials.gov